New treatment option for Healthy Subjects
Official title Peri-Implant Soft Tissue Integration in Humans: Influence of Material
ClinicalTrials.gov ID: NCT05805033
What this study is testing
- What it's testing
- The purpose of this study is to compare the mucointegration of 2 types of surface roughness of zirconia abutments with titanium. The surface roughness will be machined and ultra-polished.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participants have to voluntarily sign the informed consent form before any study related action
- Patients aged 18 or over
- Patients with one or more missing teeth in the maxillary or mandible area, seeking implant therapy
- Men/women
- Patients in good systemic health (ASA I/ II) and no contraindication for oral surgical interventions
You likely can't join if
- Autoimmune disease requiring medical treatment
- Medical conditions requiring prolonged use of steroids
- Use of Bisphosphonates intravenously or more than 3 years of oral use
- Infection (local or systemic) - patients with gingivitis or active local infection will undergo a medical treatment prior to the entrance to the...
- Current pregnancy or breastfeeding women
- Alcoholism or chronical drug abuse
See the full eligibility criteria
- Participants have to voluntarily sign the informed consent form before any study related action
- Patients aged 18 or over
- Patients with one or more missing teeth in the maxillary or mandible area, seeking implant therapy
- Men/women
- Patients in good systemic health (ASA I/ II) and no contraindication for oral surgical interventions
- Patients requiring a replacement of missing teeth; the tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation
- At least 3 mm of fibrous mucosa in the bucco-lingual dimension
- Full mouth plaque score (FMPI) lower than or equal to 25%
- At least a diameter of 4 mm for the implant (regular diameter)
- Autoimmune disease requiring medical treatment
- Medical conditions requiring prolonged use of steroids
- Use of Bisphosphonates intravenously or more than 3 years of oral use
- Infection (local or systemic) - patients with gingivitis or active local infection will undergo a medical treatment prior to the entrance to the study, and each individual will be evaluated for suitability; in case of a...
- Current pregnancy or breastfeeding women
- Alcoholism or chronical drug abuse
- Immunocompromised patients
- Uncontrolled diabetes
- Smokers
- Prisoners
- Implant's diameter under 4 mm (narrow implant)
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of the study or interference with analysis of study results, such as history of non-compliance, or unreliability
The study team makes the final eligibility decision.
Where it's taking place
- Liège, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Liège, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.